Can Whole-Blood Samples Be Stored over 24 Hours Without Compromising Stability of C-Reactive Protein, Retinol, Ferritin, Folic Acid, And Fatty Acids in Epidemiologic Research?(Technical Briefs) (Clinical Report) Can Whole-Blood Samples Be Stored over 24 Hours Without Compromising Stability of C-Reactive Protein, Retinol, Ferritin, Folic Acid, And Fatty Acids in Epidemiologic Research?(Technical Briefs) (Clinical Report)

Can Whole-Blood Samples Be Stored over 24 Hours Without Compromising Stability of C-Reactive Protein, Retinol, Ferritin, Folic Acid, And Fatty Acids in Epidemiologic Research?(Technical Briefs) (Clinical Report‪)‬

Clinical Chemistry 2005, Jan, 51, 1

    • 2,99 €
    • 2,99 €

Beschreibung des Verlags

Ideally, blood samples for biomarker measurement are collected centrally and processed immediately to avoid any unwanted changes in concentrations that could affect validity. In large-scale epidemiologic and clinical studies, however, this theoretical goal must give way to a more pragmatic approach (1, 2). The Amsterdam Born Children and their Development (ABCD) study is a clinically based cohort study of pregnant women in Amsterdam (The Netherlands) in which we use, for practical and ethical reasons, blood collection in conjunction with existing schemes of care, with samples subsequently sent to a central laboratory by mail or courier. As a consequence, delay times between collection and processing may exceed 24 h, to an incidental maximum of 96 h. Although the stabilities of the biomarkers of interest, i.e., C-reactive protein (CRP), retinol, ferritin, folic acid, and fatty acids (FAs), have been studied previously (1-9), the variety of designs (e.g., storage [less than or equal to] 24 h) hampers the applicability of existing results to our research and similar studies. We therefore investigated the appropriateness of our standardized, practice-based approach of blood collection by assessing stability in samples stored up to 96 h (the maximum delay time possible when samples are sent by mail) with a focus on the first 28 h (the maximum delay time allowed in the ABCD study). Blood samples were collected from 41 generally healthy female volunteers, 22-56 years of age. One woman was at that time 16 weeks pregnant, but because her measurements did not deviate, we decided not to exclude her from analysis. Written informed consent was obtained from all participants. For 20 women, 28 mL of blood was collected in seven 4-mL Vacuettes (Greiner BV) for the preparation of serum. For the other 21 women, 28 mL of blood was collected in seven 4-mL Vacutainer EDTA tubes (Becton and Dickinson BV) for the preparation of plasma. One tube from each woman was centrifuged (1600g for 10 min) between 1 and 2 h after blood collection (to; baseline), and the remaining tubes were stored in a cabinet at room temperature (~21[degrees]C) and centrifuged 2 ([t.sub.2]), 4 ([t.sub.4]), 24 ([t.sub.24]), 26 ([t.sub.26]), 28 ([t.sub.28]), or 96 ([t.sub.96]) h after baseline. Time points were chosen to mimic courier and postal conditions seen in the ABCD study, 4 h being the anticipated maximum delay time when blood is sent by courier, 28 h being the anticipated maximum delay time when blood is sent by overnight mail, and 96 h being the anticipated maximum delay time when blood is sent by mail but over the weekend.

GENRE
Wissenschaft und Natur
ERSCHIENEN
2005
1. Januar
SPRACHE
EN
Englisch
UMFANG
12
Seiten
VERLAG
American Association for Clinical Chemistry, Inc.
ANBIETERINFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
GRÖSSE
315,7
 kB
Can Heparin Plasma Be Used Instead of Serum for Nephelometric Analysis of Serum Proteins?(Letters) (Letter to the Editor) Can Heparin Plasma Be Used Instead of Serum for Nephelometric Analysis of Serum Proteins?(Letters) (Letter to the Editor)
2006
Interlaboratory Variation of Plasma Total Homocysteine Measurements: Results of Three Successive Homocysteine Proficiency Testing Surveys (General Clinical Chemistry) Interlaboratory Variation of Plasma Total Homocysteine Measurements: Results of Three Successive Homocysteine Proficiency Testing Surveys (General Clinical Chemistry)
2002
Immunoradiometric Assay of Circulating C-Reactive Protein: Age-Related Values in the Adult General Population (Enzymes and Protein Markers) Immunoradiometric Assay of Circulating C-Reactive Protein: Age-Related Values in the Adult General Population (Enzymes and Protein Markers)
2000
Effect of Vitamin E Supplementation with Standard Treatment on Oxidant-Antioxidant Status in Chronic Obstructive Pulmonary Disease (Report) Effect of Vitamin E Supplementation with Standard Treatment on Oxidant-Antioxidant Status in Chronic Obstructive Pulmonary Disease (Report)
2008
Fundamentals of Analytical Toxicology Fundamentals of Analytical Toxicology
2020
Metabolomics in Practice Metabolomics in Practice
2013
Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs) Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report) Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report)
2002
Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs) Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs)
2004
Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report) Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report)
2001
A Conversation with Elizabeth Blackburn (Interview) A Conversation with Elizabeth Blackburn (Interview)
2009
The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective) The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective)
1998